The Net Margin of Jafron Biomedical Co Ltd (300529.SZ) is 22.71%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2023-12-31 | 22.71% |
| 2022-12-31 | 35.70% |
| 2021-12-31 | 44.73% |
| 2020-12-31 | 44.86% |
| 2019-12-31 | 39.87% |
| 2018-12-31 | 39.55% |
| 2017-12-31 | 39.58% |
| 2016-12-31 | 37.18% |
| 2015-12-31 | 39.38% |
| 2014-12-31 | 43.14% |